Bank of America’s Vigil Neuroscience VIGL Stock Holding History

Bank of America’s Portfolio VIGL Stock Details VIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,186	Closed	-$9.43K	–	8709
2025 Q2	$9.43K	Buy	1,186 +80	+7%	+$359	﹤0.01%	7207
2025 Q1	$1.97K	Buy	1,106 +9	+0.8%	+$20	﹤0.01%	7337
2024 Q4	$1.86K	Sell	1,097 -22,366	-95%	-$66K	﹤0.01%	7205
2024 Q3	$79.8K	Sell	23,463 -3,334	-12%	-$12.3K	﹤0.01%	6415
2024 Q2	$107K	Buy	26,797 +7,858	+41%	+$26.9K	﹤0.01%	6230
2024 Q1	$64.6K	Sell	18,939 -10,095	-35%	-$31.5K	﹤0.01%	6435
2023 Q4	$98.1K	Buy	29,034 +5,433	+23%	+$28K	﹤0.01%	6381
2023 Q3	$127K	Buy	23,601 +3,468	+17%	+$24K	﹤0.01%	6139
2023 Q2	$189K	Buy	20,133 +811	+4%	+$7.67K	﹤0.01%	5872
2023 Q1	$189K	Buy	19,322 +9,426	+95%	+$106K	﹤0.01%	5946
2022 Q4	$124K	Buy	+9,896	New	+$121K	﹤0.01%	6150
2022 Q2	–	Sell	-1,519	Closed	-$11K	–	8411
2022 Q1	$11K	Buy	+1,519	New	+$20K	﹤0.01%	7718

Other funds holding VIGL

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Bank of America's VIGL Position: Q3 2025 in Review

Bank of America sold out of Vigil Neuroscience (VIGL) in Q3 2025, closing a stake of 1,186 shares — an estimated $9.43K sold.

Bank of America first reported a position in VIGL in Q1 2022 and held it in 12 quarters. The position peaked at $189K in Q2 2023. 2 funds tracked by Wall St. Rank hold VIGL as of Q3 2025.

Bank of America reported no remaining Vigil Neuroscience position as of Q3 2025 after selling out during the quarter.
Bank of America sold 1,186 Vigil Neuroscience shares in Q3 2025, an estimated $9.43K.
Bank of America first reported a position in Vigil Neuroscience in Q1 2022 and held it in 12 quarters.
Bank of America's Vigil Neuroscience position peaked at $189K in Q2 2023.
2 funds tracked by Wall St. Rank held Vigil Neuroscience as of Q3 2025.

Based on Bank of America's 13F filing for Q3 2025, filed 14 Nov 2025.